NewcelX Ltd. (NasdaqCM: NCEL)
Health Care · Biotechnology · CH
$2.50
-17.90% today · -65.7% 1Y
NewcelX Ltd. (NasdaqCM: NCEL) operates in the Biotechnology industry within the Health Care sector. The company is valued at $14.44M and employs 11 people.
Over the last twelve months the share price has lost 65.7%, trading between 1.83 and 7.64.
Tweenvest scores NewcelX Ltd. across four factors: quality 30/100, value 55/100. Its strongest factor is value.
NCEL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $14.44M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.51
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $7.64
- 52-week low
- $1.83
- Avg volume (3M)
- —
- Shares outstanding
- 5.78M
- Employees
- 11
- Next earnings
- —
About NewcelX Ltd.
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.
- ISIN
- CH1442297896
- Founded
- 2008
- Listed since
- Oct 24, 2025
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Poongjeon Pharmacy CO.,LTD.KOSDAQ: A298060 | $14.56M | ₩2,195.00 | -5.39% |
| Actuate Therapeutics, Inc.NasdaqGM: ACTU | $14.53M | $0.61 | -0.85% |
| Initiator Pharma A/SOM: INIT | $14.45M | Skr2.09 | +16.11% |
| FunPep Company LimitedTSE: 4881 | $14.44M | ¥45.00 | +2.27% |
| Aptamer Group PLCAIM: APTA | $14.29M | £0.00 | -4.62% |
| Allarity Therapeutics, Inc.NasdaqCM: ALLR | $14.24M | $0.90 | -9.60% |
| Abera Bioscience ABNGM: ABERA | $14.09M | Skr— | — |
| Pasithea Therapeutics Corp.NasdaqCM: KTTA | $14.03M | $0.42 | -10.16% |
Figures last refreshed Oct 18, 2026.